Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-074495
Filing Date
2018-12-21
Accepted
2018-12-21 17:03:19
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 5 a5.html 5  
1 5 a5.xml 5 6173
  Complete submission text file 0001104659-18-074495.txt   7543
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36812 | Film No.: 181250360

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations